13 oct 2020
CPhI Worldwide 2020
Taiwan Pharmaceutical Alliance

Taiwan Pharmaceutical Alliance

Exhibitor at CPhI Worldwide 2020 stand 5A16

About us

Taiwan Pharmaceutical Alliance (TPA)  comprises several Taiwan-based API and FDF generic manufacturers.  It's established with the goal of integrating the strength of Taiwan industry and providing one-stop services for oversea partners.  Some niche products of TPA include MDI/ DPI, liposome & microsphere injectables, high-potent soft gel, OROS tablets, eye drops and biosimilar etc.  TPA could also provide CDMO/ CMO, license in/out, and trading services.  Taiwan is a PIC/S and ICH member.  All TPA facilities pass PIC/S GMP and some of them are USFDA, EU, and/or Japan PMDA GMP inspected.  TPA is your trustworthy partner in the dynamic markets.

Specs about this supplier

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Central/South America
Affiliated categories: API Contract Manufacturing |Biopharmaceuticals (general category) |Custom Manufacturing of Dosage Form Drugs More

Products featured at CPhI Worldwide 2020

Taiwan Pharmaceutical Alliance

Event information

CPhI Worldwide 2020

13 - 15 October 2020 Milan, Italy Visit us at stand 5A16